TECHBio-Techne
Is it growing?
Growing: earnings up +150% year on year and operating margin widening (+12.0 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +5% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.
Trailing-twelve-month operating margin, 20.6% now against 8.6% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is TECH growing?
Bio-Techne has grown revenue 2.3% a year over three years and 5.5% a year over five, with earnings per share compounding at −13%.
Revenue growth, 3-year annual rate · Biotechnology median +17% · growing slowly · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +5.5%
Revenue growth, 5-year rate · +2.3% over three · growth has slowed since the five-year average
- Earnings per share, 3-year rate
- −13%
Earnings per share, 3-year rate · revenue +2.3% · earnings lagged revenue: the growth is costing something
- Years of annual history on file
- 18
Years of annual history on file · FY2009 to FY2026, as filed
Details›
- Revenue FY2022
- $1.11B
- Revenue FY2023
- $1.14B
- Revenue FY2024
- $1.16B
- Revenue FY2025
- $1.22B
- Revenue FY2026
- $1.22B
Annual income statements as filed with the SEC.
Biotechnology
The closest names by size in the same industry